Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.

Zhou C, Zhou HJ, Zhang XF, Lou LL, Ye QH, Zheng Y, Wang J, Zhu HT, Dong QZ, Jia HL, Zhu WW, Guo L, Zhao Y, Gao DM, Qin LX.

Ann Surg Oncol. 2013 Mar;20(3):929-37. doi: 10.1245/s10434-012-2749-9. Epub 2012 Dec 1.

PMID:
23203407
2.

The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.

Zhang H, Ye QH, Ren N, Zhao L, Wang YF, Wu X, Sun HC, Wang L, Zhang BH, Liu YK, Tang ZY, Qin LX.

J Cancer Res Clin Oncol. 2006 Nov;132(11):709-17. Epub 2006 Jun 20.

PMID:
16786357
3.

High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL.

Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31.

PMID:
23916473
4.

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

Kim J, Ki SS, Lee SD, Han CJ, Kim YC, Park SH, Cho SY, Hong YJ, Park HY, Lee M, Jung HH, Lee KH, Jeong SH.

Am J Gastroenterol. 2006 Sep;101(9):2051-9. Epub 2006 Jul 18.

PMID:
16848813
5.
6.

Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.

Blank S, Wang Q, Fiel MI, Luan W, Kim KW, Kadri H, Mandeli J, Hiotis SP.

Ann Surg Oncol. 2014 Mar;21(3):986-94.

PMID:
24232510
7.

[Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].

Cui BK, Zhang CQ, Zhang Y, Yuan YF, Zhang YQ, Shi M, Chen MS, Li SP, Li JQ.

Ai Zheng. 2006 Jul;25(7):876-9. Chinese.

PMID:
16831281
8.

Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.

Zhang XF, Yin ZF, Wang K, Zhang ZQ, Qian HH, Shi LH.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23.

9.

The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.

Sun J, Xu HM, Zhou HJ, Dong QZ, Zhao Y, Fu LY, Hei ZY, Ye QH, Ren N, Jia HL, Qin LX.

J Cancer Res Clin Oncol. 2010 Jan;136(1):1-7. doi: 10.1007/s00432-009-0629-x.

PMID:
19593583
10.

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.

Xie H, Song J, Du R, Liu K, Wang J, Tang H, Bai F, Liang J, Lin T, Liu J, Fan D.

Dig Liver Dis. 2007 Feb;39(2):167-72. Epub 2006 Dec 11.

PMID:
17161983
11.

Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.

Zhu W, Guo L, Zhang B, Lou L, Lin Z, Zhu X, Ren N, Dong Q, Ye Q, Qin L.

Ann Surg Oncol. 2014 Apr;21(4):1304-13. doi: 10.1245/s10434-013-3445-0. Epub 2013 Dec 24.

PMID:
24366422
12.

Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.

Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, Rahem DA, Sayed D.

Ann Hepatol. 2011 Jul-Sep;10(3):296-305.

13.

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.

Blasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, Donington JS.

J Clin Oncol. 2010 Feb 20;28(6):936-41. doi: 10.1200/JCO.2009.25.5711. Epub 2010 Jan 19.

14.

Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.

Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.

Ann Surg Oncol. 2009 Oct;16(10):2795-804. doi: 10.1245/s10434-009-0618-y. Epub 2009 Aug 11.

PMID:
19669841
15.

Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma.

Shiba H, Furukawa K, Fujiwara Y, Futagawa Y, Haruki K, Wakiyama S, Ishida Y, Misawa T, Yanaga K.

Anticancer Res. 2013 Feb;33(2):705-9.

PMID:
23393371
16.

Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.

Zhu WJ, Huang CY, Li C, Peng W, Wen TF, Yan LN, Li B, Wang WT, Xu MQ, Yang JY, Jiang L.

Asian Pac J Cancer Prev. 2013;14(12):7101-6.

17.

Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.

Mathews P, Lee D, Chung YH, Kim JA, Lee JH, Jin YJ, Park W, Lyu H, Jaffee E, Zheng L, Yu E, Lee YJ.

Ann Surg Oncol. 2013 Apr;20(4):1216-22. doi: 10.1245/s10434-012-2706-7. Epub 2012 Oct 27.

18.

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.

Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC.

Eur J Surg Oncol. 2012 Aug;38(8):683-91. doi: 10.1016/j.ejso.2012.04.010. Epub 2012 May 22.

PMID:
22621971
19.

Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.

Zhang XF, Lai EC, Kang XY, Qian HH, Zhou YM, Shi LH, Shen F, Yang YF, Zhang Y, Lau WY, Wu MC, Yin ZF.

Ann Surg Oncol. 2011 Aug;18(8):2218-23. doi: 10.1245/s10434-011-1613-7. Epub 2011 Feb 20.

PMID:
21336512
20.

Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.

Nobuoka D, Kato Y, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T, Nakatsura T.

Oncol Rep. 2010 Aug;24(2):521-8.

PMID:
20596642
Items per page

Supplemental Content

Write to the Help Desk